Literature DB >> 9500499

The influence of pregnancy on human immunodeficiency virus type 1 infection: antepartum and postpartum changes in human immunodeficiency virus type 1 viral load.

D N Burns1, S Landesman, H Minkoff, D J Wright, D Waters, R M Mitchell, A Rubinstein, A Willoughby, J J Goedert.   

Abstract

OBJECTIVE: Our objective was to examine the influence of pregnancy on human immunodeficiency virus type 1 viral load by measuring human immunodeficiency virus type 1 ribonucleic acid levels during pregnancy and post partum. STUDY
DESIGN: One or more plasma or serum specimens obtained before and during the third trimester, and at 2, 12, and 24 months post partum were available for 160 human immunodeficiency virus type 1-seropositive women enrolled in the Mothers and Infants Cohort Study between January 1986 and January 1991. All specimens were frozen and stored at -70 degrees C until analyzed in batch for human immunodeficiency virus type 1 ribonucleic acid by polymerase chain reaction. A multivariate longitudinal random effects model was developed to examine changes in human immunodeficiency virus type 1 ribonucleic acid levels over time.
RESULTS: Overall, human immunodeficiency virus type 1 ribonucleic acid levels rose significantly during the study period, particularly during the second year post partum (mean, 0.09 log per year; 95% confidence interval, 0.03 to 0.15 logs per year; p = 0.005). However, the mean slope during pregnancy was not significantly different from zero (p = 0.65).
CONCLUSION: Pregnancy had little immediate effect on human immunodeficiency virus type 1 viral load in most human immunodeficiency virus type 1-seropositive women.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500499     DOI: 10.1016/s0002-9378(98)80025-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.

Authors:  Jose H Pilotto; Luciane S Velasque; Ruth K Friedman; Ronaldo I Moreira; Valdilea G Veloso; Beatriz Grinsztejn; Mariza G Morgado; D Heather Watts; Judith S Currier; Risa M Hoffman
Journal:  Antivir Ther       Date:  2011

2.  Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150.

Authors:  Beverly E Sha; Camlin Tierney; Susan E Cohn; Xin Sun; Robert W Coombs; Lisa M Frenkel; Spyros A Kalams; Francesca T Aweeka; Barbara Bastow; Arlene Bardeguez; Anne Kmack; Alice Stek
Journal:  HIV Clin Trials       Date:  2011 Jan-Feb

3.  Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.

Authors:  Risa M Hoffman; Erin Leister; Deborah Kacanek; David E Shapiro; Jennifer S Read; Yvonne Bryson; Judith S Currier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

4.  Factors associated with desire for children among HIV-infected women and men: a quantitative and qualitative analysis from Malawi and implications for the delivery of safer conception counseling.

Authors:  Paul Kawale; Deborah Mindry; Stephanie Stramotas; Peter Chilikoh; Ann Phoya; Katherine Henry; David Elashoff; Perry Jansen; Risa Hoffman
Journal:  AIDS Care       Date:  2013-11-06

5.  HCV adaptations to altered CD8+ T-cell immunity during pregnancy.

Authors:  Aryn A Price; Arash Grakoui; Jonathan R Honegger
Journal:  Future Virol       Date:  2014-04-01       Impact factor: 1.831

6.  Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

7.  Viral Load Monitoring in HIV Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

8.  Pregnancy and virologic response to antiretroviral therapy in South Africa.

Authors:  Daniel Westreich; Stephen R Cole; Shashi Nagar; Mhairi Maskew; Charles van der Horst; Ian Sanne
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.